Michael T. Beste

1.5k total citations · 1 hit paper
24 papers, 1.0k citations indexed

About

Michael T. Beste is a scholar working on Immunology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Michael T. Beste has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Reproductive Medicine and 5 papers in Obstetrics and Gynecology. Recurrent topics in Michael T. Beste's work include Endometriosis Research and Treatment (6 papers), Cell Adhesion Molecules Research (5 papers) and Uterine Myomas and Treatments (4 papers). Michael T. Beste is often cited by papers focused on Endometriosis Research and Treatment (6 papers), Cell Adhesion Molecules Research (5 papers) and Uterine Myomas and Treatments (4 papers). Michael T. Beste collaborates with scholars based in United States, Switzerland and Singapore. Michael T. Beste's co-authors include Linda G. Griffith, Douglas A. Lauffenburger, Keith Isaacson, Daniel A. Hammer, Paul M. Ridker, E. C. Svensson, Margaret L. Healey, Yunsheng He, Marc Sultan and Huilei Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Circulation.

In The Last Decade

Michael T. Beste

24 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TET2-Driven Clonal Hematopoiesis and Response to Canakinumab

2022 218 citations E. C. Svensson, Aviv Madar et al. profile →

Peers

Countries citing papers authored by Michael T. Beste

Since Specialization

Citations

This map shows the geographic impact of Michael T. Beste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Beste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Beste more than expected).

Fields of papers citing papers by Michael T. Beste

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael T. Beste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Beste. The network helps show where Michael T. Beste may publish in the future.

Co-authorship network of co-authors of Michael T. Beste

This figure shows the co-authorship network connecting the top 25 collaborators of Michael T. Beste. A scholar is included among the top collaborators of Michael T. Beste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael T. Beste. Michael T. Beste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial 2024 ·Cancer Prevention Research ·Janghee Woo, (unknown), (unknown), Huilei Xu, Margaret L. Healey, Denise P. Yates, Michael T. Beste, David P. Steensma	4
2	Effects of IL-1β inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial 2023 ·Blood Advances ·Janghee Woo, Darlene Lu, Andrew Lewandowski, Huilei Xu, Pablo Serrano Balazote, Margaret L. Healey, Denise P. Yates, Michael T. Beste, Peter Libby, Paul M. Ridker, David P. Steensma	23
3	Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background 2023 ·The American Journal of Human Genetics ·(unknown), Konstantin Shestopaloff, Benjamin Hollis, (unknown), (unknown), Nicole Hartmann, (unknown), Magdalena Woźniak, Luís Santos, (unknown), (unknown), Ann‐Marie Mallon, Aimee Readie, Ruvie Martin, Thomas E. Nichols, Michael T. Beste, Jonas Zierer, Enrico Ferrero, Marc Vandemeulebroecke, Luke Jostins-Dean	6
4	Endometrial cytokines in patients with and without endometriosis evaluated for infertility 2022 ·Fertility and Sterility ·(unknown), Péter Fedorcsák, Keith Isaacson, (unknown), (unknown), Michael T. Beste, Erik Qvigstad, Douglas A. Lauffenburger, Linda G. Griffith	15
5	First-in-human trial results of LNA043, a novel cartilage regenerative treatment for osteoarthritis 2021 ·Osteoarthritis and Cartilage ·Celeste Scotti, Joseph Gimbel, Didier Laurent, Aviv Madar, (unknown), (unknown), (unknown), Michael T. Beste, Igor Voštiar, (unknown), Nicole Gerwin, Jörg Goldhahn, Matthias Schieker, Ronenn Roubenoff	1
6	Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial 2020 ·Cancer Research ·Connie Wong, Jason Baum, (unknown), Michael T. Beste, (unknown), Siyan Xu, Ying A. Wang, Tony Wang, Margaret F. Prescott, (unknown), Margaret Dugan, Paul M. Ridker, Anne‐Marie Martin, E. C. Svensson	63
7	Endometrioma, the follicular fluid inflammatory network and its association with oocyte and embryo characteristics 2019 ·Reproductive BioMedicine Online ·Jennifer J. Yland, (unknown), Michael T. Beste, Amelia P. Bailey, (unknown), Maurício Simões Abrão, Catherine Racowsky, Linda G. Griffith, Stacey A. Missmer	29
8	Identifying Key Pathways and Components in Chemokine-Triggered T Lymphocyte Arrest Dynamics Using a Multi-Parametric Global Sensitivity Analysis 2019 ·Cellular and Molecular Bioengineering ·Dooyoung Lee, Michael T. Beste, Nicholas R. Anderson, Gary A. Koretzky, Daniel A. Hammer	3
9	Abstract 15111: TET2-Driven Clonal Hematopoiesis Predicts Enhanced Response to Canakinumab in the CANTOS Trial: An Exploratory Analysis 2018 ·Circulation ·E. C. Svensson, Aviv Madar, Catarina D. Campbell, Yunsheng He, Marc Sultan, Margaret L. Healey, (unknown), Anita Fernandez, (unknown), Paul M. Ridker, Michael T. Beste, Craig T. Basson	32
10	Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double‐blind, placebo‐controlled study 2018 ·Allergy ·Martin Metz, Rebecca I. Torene, Sérgio Kaiser, Michael T. Beste, Petra Staubach, Andrea Bauer, Randolf Brehler, Janine Gericke, Martin Letzkus, Nicole Hartmann, Veit J. Erpenbeck, Marcus Maurer	26
11	Peritoneal fluid cytokines related to endometriosis in patients evaluated for infertility 2017 ·Fertility and Sterility ·(unknown), (unknown), Michael T. Beste, Manu P. Kumar, Evan L. Chiswick, Péter Fedorcsák, Keith Isaacson, Douglas A. Lauffenburger, Linda G. Griffith, Erik Qvigstad	94
12	Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation 2017 ·The Lancet Neurology ·Jeanne C. Latourelle, Michael T. Beste, Tiffany C. Hadzi, Robert E. Miller, (unknown), (unknown), Diane Wuest, Bruce W. Church, Iya Khalil, Boris Hayete, Charles S. Venuto	106
13	Immobilized IL-8 Triggers Phagocytosis and Dynamic Changes in Membrane Microtopology in Human Neutrophils 2015 ·Annals of Biomedical Engineering ·Michael T. Beste, Elena B. Lomakina, Daniel A. Hammer, Richard E. Waugh	23
14	ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling 2013 ·Proceedings of the National Academy of Sciences ·Miles A. Miller, Aaron S. Meyer, Michael T. Beste, (unknown), (unknown), (unknown), Chia‐Hung Chen, (unknown), Keith Isaacson, Linda G. Griffith, Douglas A. Lauffenburger	75
15	High-Throughput Mutiplexed Protease Activity Measurement Using a Droplet Based Microfluidic Platform with Picoinjector 2012 ·DSpace@MIT (Massachusetts Institute of Technology) ·Chia‐Hung Chen, Miles A. Miller, Aniruddh Sarkar, Michael T. Beste, Douglas A. Lauffenburger, Linda G. Griffith, Jongyoon Han	1
16	Diacylglycerol kinase zeta negatively regulates CXCR4-stimulated T lymphocyte firm arrest to ICAM-1 under shear flow 2012 ·Integrative Biology ·Dooyoung Lee, (unknown), Michael T. Beste, Gary A. Koretzky, Daniel A. Hammer	6
17	Multiplexed Protease Activity Assay for Low-Volume Clinical Samples Using Droplet-Based Microfluidics and Its Application to Endometriosis 2012 ·Journal of the American Chemical Society ·Chia‐Hung Chen, Miles A. Miller, Aniruddh Sarkar, Michael T. Beste, Keith Isaacson, Douglas A. Lauffenburger, Linda G. Griffith, Jongyoon Han	73
18	An Integrated Stochastic Model of “Inside-Out” Integrin Activation and Selective T-Lymphocyte Recruitment 2011 ·Langmuir ·Michael T. Beste, Dooyoung Lee, Michael R. King, Gary A. Koretzky, Daniel A. Hammer	10
19	Optimization of ultrasound contrast agents with computational models to improve selection of ligands and binding strength 2010 ·Biotechnology and Bioengineering ·Timothy M. Maul, (unknown), Michael T. Beste, Daniel A. Hammer, John S. Lazo, Flordeliza S. Villanueva, William R. Wagner	31
20	Steady-State Multiplicity in Receptor-Mediated Colloidal Adhesion 2007 ·The Journal of Physical Chemistry C ·Michael T. Beste, Daniel A. Hammer	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact